Study guide

10.3 Tricuspid Stenosis Assessment

CCI Registered Cardiac Sonographer RCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: RCS Orientation and Clinical Context

1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context

2 Chapter 2: Orders, Safety, and Patient Preparation

2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare

3 Chapter 3: Reporting and 2-D TTE Foundations

3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA

4 Chapter 4: M-Mode and Doppler Acquisition

4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition

5 Chapter 5: Advanced Doppler and Contrast

5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts

6 Chapter 6: Stress Echocardiography

6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation

7 Chapter 7: TEE, Strain, and 3-D TEE

7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts

8 Chapter 8: 3-D TTE and the Aortic Valve

8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

9 Chapter 9: Aortic Regurgitation and Mitral Structure

9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability

10 Chapter 10: Mitral and Tricuspid Valve Findings

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment

11 Chapter 11: Right-Sided Valve Disease

11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment

12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves

12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch

13 Chapter 13: Endocarditis and Cardiac Chambers

13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function

14 Chapter 14: Cardiomyopathy Phenotypes and Diastology

14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls

15 Chapter 15: Systolic Function and Ischemia

15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications

16 Chapter 16: Pericardium and Great Vessels

16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation

17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition

17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues

18 Chapter 18: Devices, Strain, and Hemodynamics

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

19 Chapter 19: Infiltrative Disease and Physics Foundations

19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing

20 Chapter 20: Resolution and Doppler Optimization

20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain

21 Chapter 21: 2-D, 3-D, and Contrast Optimization

21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts

10.3 Tricuspid Stenosis Assessment

Key Takeaways Explain This Topic AI

Tricuspid stenosis is uncommon and usually rheumatic; confirm restricted opening and commissural or leaflet disease while searching for associated mitral disease and alternative levels of right-heart inflow obstruction.

Acquire low-velocity diastolic inflow with careful CW alignment over multiple respiratory cycles and report heart rate and rhythm because respiration, tachycardia, and atrial fibrillation materially change the gradient.

Integrate valve morphology, mean diastolic gradient, flow state, pressure half-time or valve area when technically defensible, and RA/IVC/hepatic consequences; no isolated cutoff proves severity.

Pressure half-time is strongly affected by right-sided compliance and respiration, while continuity area can be underestimated by important TR; planimetry is limited by the tricuspid valve's nonplanar geometry.

Last updated: July 2026

Confirm that obstruction is valvar and define the cause

CCI task C8 requires assessment of tricuspid stenosis (TS). TS is rare and most often rheumatic, usually accompanying mitral-valve disease. Rheumatic morphology includes leaflet thickening, restricted excursion, doming, commissural fusion, and subvalvular shortening; combined stenosis and regurgitation is common. Other causes include congenital malformation, carcinoid-related thickening and retraction, endocarditic destruction or bulky vegetation, tumor, and device- or procedure-related obstruction. A mass in the RA, cor triatriatum dexter membrane, or external inflow compression can mimic valvar obstruction, so locate the narrowest level before applying a valve label.

Use RV-focused apical four-chamber, parasternal RV-inflow, parasternal short-axis, and subcostal sweeps. Zoom the valve during diastole, documenting leaflet thickness, mobility, commissural fusion, opening shape, coexisting regurgitation, and any lead or mass. Color Doppler with a low Nyquist limit helps localize diastolic acceleration but does not grade severity. Search for associated rheumatic mitral or aortic disease and record RA size, IVC size and respiratory response, hepatic-vein flow when relevant, RV size and function, and estimated pulmonary pressure. Marked RA and systemic venous dilation may support chronic inflow obstruction, but these findings are not specific and can result from severe TR or RV failure.

Acquire right-sided hemodynamics deliberately

Align CW Doppler as parallel as possible to tricuspid inflow from the view with the cleanest complete diastolic envelope. Use a low velocity scale, low wall filter, adequate sweep speed, and gain that shows the dense modal signal without tracing noise. Record several respiratory cycles because tricuspid velocity normally rises with inspiration. In sinus rhythm, trace representative complete envelopes at a consistent respiratory phase according to laboratory convention; in atrial fibrillation, average multiple beats with comparable R-R intervals and avoid postectopic cycles. Always report heart rate and rhythm.

Trace the dense diastolic envelope for mean gradient . Do not substitute the peak gradient: mean gradient better represents the pressure burden throughout filling. A mean gradient around 5 mmHg or greater at a normal heart rate supports hemodynamically significant TS in the appropriate anatomic setting, but gradient is flow and rate dependent. Tachycardia shortens diastole and raises the mean gradient; high flow from significant TR or a left-to-right shunt can do the same. Low output can produce a deceptively low gradient despite a small orifice.

Finding Supportive pattern Why it cannot stand alone

Morphology Thickened restricted leaflets, doming, fusion Poor windows or nonvalvar obstruction can mimic restriction

Mean gradient Elevated across a complete diastolic envelope Varies with heart rate, flow, respiration, and rhythm

Pressure half-time Prolonged decay, often over 190 ms in important TS Depends on RA/RV compliance, relaxation, respiration, and TR

Valve area Small planimetered or calculated orifice, about 1.0 cm² or less Each method has geometric or flow assumptions

Consequences RA/IVC dilation and systemic venous congestion Severe TR and RV disease produce similar findings

Pressure half-time (PHT) measures the time for the initial transvalvular pressure gradient to fall by half. Unlike mitral stenosis, a simple mitral-style constant should not be applied blindly to TS. Right-atrial and right-ventricular compliance, RV relaxation, respiration, heart rate, and coexisting TR alter the decay slope. If PHT is reported, average technically appropriate beats and interpret a prolonged value only as one supportive finding.

For continuity assessment:

Tricuspid valve area = forward stroke volume / tricuspid inflow VTI

The stroke-volume source and inflow VTI must represent the same physiologic state. Important TR causes the tricuspid inflow to include recirculated regurgitant volume, so a continuity-derived area can be falsely small; shunts or important pulmonary regurgitation also violate flow equivalence. Diameter error at the chosen outflow site is squared, and irregular rhythm compounds mismatch. A calculated area should be rejected or qualified when these assumptions fail, not accepted because it appears precise.

Direct two-dimensional planimetry is difficult because the tricuspid annulus and orifice are nonplanar and mobile. An oblique cut overestimates area, while leaflet dropout can create a false opening. Three-dimensional acquisition with multiplanar reconstruction can help align a plane at the smallest diastolic orifice, but thin tissue, stitching, temporal resolution, and gain remain limiting. Confirm the traced border in orthogonal source planes.

Reconcile severity instead of choosing a favorite number

A convincing important-TS pattern combines appropriate morphology, persistent diastolic acceleration, an elevated mean gradient at a documented reasonable heart rate, supportive area or PHT when valid, and compatible right-sided consequences. A small area near or below 1.0 cm² or PHT above about 190 ms can support the conclusion, but neither replaces the integrated assessment. State whether regurgitation, shunt, tachycardia, AF, low output, or poor alignment limits interpretation.

When numbers conflict, first confirm that CW sampled tricuspid rather than mitral or another jet, then review scale, filter, alignment, tracing, respiratory phase, beat selection, heart rate, flow state, and stroke-volume source. Reacquire after rate or loading conditions change when clinically feasible and authorized. Do not label severe TS from a gradient obtained at rapid AF without showing valve anatomy; conversely, do not dismiss a restricted fused valve because low output keeps the gradient below a cutoff.

Report the cause and level of obstruction, leaflet and commissural morphology, mean gradient with heart rate and rhythm, PHT and area method with limitations, coexisting TR and other valve disease, and RA/RV/IVC/hepatic findings. Promptly communicate a large obstructing mass, suspected infection, device-associated obstruction, or hemodynamic compromise. This transparent record allows the interpreter to decide whether TEE, 3-D imaging, catheter hemodynamics, or another modality is needed.